Rifamate Interactions
There are 900 drugs known to interact with Rifamate (isoniazid/rifampin), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 282 are major, 593 are moderate, and 25 are minor.
- View all 900 medications that may interact with Rifamate
- View Rifamate alcohol/food interactions (2)
- View Rifamate disease interactions (11)
Most frequently checked interactions
View interaction reports for Rifamate (isoniazid / rifampin) and the medicines listed below.
- acetylcysteine
- acyclovir
- allopurinol
- amitriptyline
- ampicillin
- atorvastatin
- ceftriaxone
- citalopram
- clonazepam
- colchicine
- ethambutol
- gabapentin
- Iron Sulfate (ferrous sulfate)
- linagliptin
- loperamide
- loratadine
- metformin
- methadone
- morphine
- omeprazole
- ondansetron
- Paracetamol (acetaminophen)
- phenazopyridine
- polyethylene glycol 3350
- prednisone
- risperidone
- senna
- sertraline
- spironolactone
- sulfamethoxazole / trimethoprim
Rifamate alcohol/food interactions
There are 2 alcohol/food interactions with Rifamate (isoniazid / rifampin).
Rifamate disease interactions
There are 11 disease interactions with Rifamate (isoniazid / rifampin) which include:
- colitis
- hepatotoxicity
- liver disease
- peripheral neuropathy
- hematopoietic disturbances
- hepatotoxicity
- liver disease
- porphyria
- hemodialysis
- renal dysfunction
- enzyme induction
More about Rifamate (isoniazid / rifampin)
- Rifamate consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antituberculosis combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.